Kelly B Moran

US Patent:

7177695, Feb 13, 2007

Filed:

Dec 17, 2001

Appl. No.:

10/023502

Inventors:

Kelly Moran - Wilbraham MA, US

Assignee:

CefamOptec Industries, Inc. - East Longmeadow MA

International Classification:

A61N 5/067

US Classification:

607 50, 607 93, 607 89

Abstract:

A device and method is disclosed for the treatment of early stage wounds, i. e. those wounds that have resulted in little or no breach of the skin tissue. The invention utilizes non-ablative laser or non-coherent electromagnetic radiation applied to a stage one or two wound to stimulate wound healing, destroy viral and bacterial bodies, and prevent the development of such wounds into higher stage wounds. An appropriate wavelength is chosen from the range of 193 nm to 10. 6 microns, and is delivered at a power density of about at least 1 W/cmover a predetermined treatment duration typically in the range of 1 second to 3 minutes. To achieve the desired energy density, radiation is typically delivered at a power between 1 Watt and 15 Watts, with an average power of 5–10 Watts. Early stage wounds that can be addressed with this invention include but are not limited to spider or other insect bites, bee stings, rashes, eczema, psoriasis, and poison ivy. The present invention is especially useful for patients with a compromised ability to heal or stave off infection due to diabetes or other conditions.

US Patent:

20030125783, Jul 3, 2003

Filed:

Dec 18, 2001

Appl. No.:

10/022989

Inventors:

Kelly Moran - Wilbraham MA, US

Assignee:

CeramOptec Industries, Inc.

International Classification:

A61N005/067

US Classification:

607/089000

Abstract:

A method and device is disclosed for wound debridement and wound healing that is equally effective for both diabetic and non-diabetic patients. A non-ablative laser beam or non-coherent radiation of a wavelength between 193 nm and 10.6 microns, preferably between 400 and 1350 nm, is applied in combination with a mechanical or laser debriding apparatus. The radiation is delivered at a power density of at least approximately 1 W/cmover a time period ranging from 1 second to 3 minutes. Typically, radiation power is in the range of 1 Watt to 15 Watts. Power density and treatment duration are adjusted to the parameters of the individual wound. Delivery means include, but are not limited to, optical fibers, articulating arms or direct exposure to radiation-emitting sources. In a preferred embodiment, pulsed or continuous wave high power radiation of an appropriate wavelength and a laser or mechanical scraping apparatus are intermittently or simultaneously applied to a wound. This device can be used on wounds of various depths to drastically cut down on the healing time by killing viral bodies and bacteria and performing other tasks such as vascularization.

US Patent:

20060106374, May 18, 2006

Filed:

Sep 29, 2005

Appl. No.:

11/238391

Inventors:

Kelly Moran - Wilbraham MA, US

International Classification:

A61B 18/18

US Classification:

606016000

Abstract:

An expendable optical fiber suitable for use in endoscopic medical treatments with a variety of light sources is described. The inventive fiber has means for determining the fiber's cumulative use history and means for enhancing visualization at the treatment site. The means for determining the fiber's cumulative use history and the means for enhancing visualization are located along predetermined portions of the fiber's surface. The inventive fiber provides for optimal color contrast and background for performing medical procedures and allows for the rapid determination of a fiber's cumulative use history by visual inspection.

US Patent:

20070106286, May 10, 2007

Filed:

Nov 3, 2006

Appl. No.:

11/592598

Inventors:

Alexander Harschack - Bad Honnef, DE
Wolfgang Neuberger - F.T. Labuan, MY
Kelly Moran - Wilbraham MA, US

International Classification:

A61B 18/18
G02B 6/028
G02B 6/02
G02F 1/295

US Classification:

606017000, 606015000, 385004000, 385124000

Abstract:

An optical fiber treatment system is provided for high power laser transmission to an area of medical treatment. A side fire optical fiber tip for use in high power laser applications having outputs of greater than or equal to 50 Watts is a key to the system. Embodiments are particularly appropriate for the medical treatment of benign prostate hyperplasia (BPH) with a side fire optical fiber tip using a Holmium:YAG laser or a high power diode laser. Such procedures can be done with only local anesthesia A predetermined length of an output tip on the distal end of the optical fiber of the present invention is formed with an optical fiber core and cladding layer of preselected thickness wherein the cladding to core diameter ratio is at least as great as 1.2. A side fire surface is formed on the distal end of the core/clad output end. Over this optical fiber output end, a pure silica capillary tube is fused to the predetermined length of exposed cladding where the outermost cladding is also pure silica to reduce thermal mismatch during the fusion process. By having the refractive index at the fusing interface of the tube to the cladding matched, and bubbles or gaps eliminated or prevented, it is possible to substantially eliminate Fresnel reflection losses at this interface. Further, the outer surface area where the laser energy is exiting from the tube may be heat treated with a laser to increase durability for high power laser energy transmission in fluid environments. Germanium-doped silica as well as pure silica can be used as fiber core material.

US Patent:

20090005767, Jan 1, 2009

Filed:

May 19, 2008

Appl. No.:

12/123114

Inventors:

KELLY B. MORAN - Wilbraham MA, US
David S. Turk - Broadview Heights OH, US

International Classification:

A61B 18/18

US Classification:

606 10

Abstract:

A method and device is provided for high power BPH laser treatments in a doctor's office or clinic setting wherein only local anesthetics are employed, making the treatments administrable in a doctor's office or a clinic, and allowing the patient to remain conscious throughout the procedure so that the doctor can interact with the patient while administering the treatment. The BPH treatments can be administered in a single short duration, i.e., each session lasting for not more than about 45 minutes and having a lasing time within the range of about 10 minutes to about 20 minutes, thus limiting the amount of discomfort and anxiety a patient might experience. The relatively high power treatment coupled with the relatively short treatment time allows doctors to assess the results of the treatment session within minutes after completing the procedure. The high power BPH laser treatments are ablative in nature wherein laser radiation is provided, generally in a pulsed mode, at preselected power output levels of at least about 100 Watts at wavelengths of 980 m and/or 1460 nm. The device includes a stable high power laser source and an optical fiber optically connected to the laser source that is capable of carrying high power laser radiation. The device is mobile and/or portable and can be operated with a standard 110/220 volt alternating current (AC) power source.

US Patent:

60863633, Jul 11, 2000

Filed:

Nov 19, 1998

Appl. No.:

9/195783

Inventors:

Kelly Moran - Wilbraham MA
Jane Morello - Wilbraham MA
Bill Siminovsky - Parkland FL
John Stambaugh - Wilbraham MA
Carol Morello - Wilbraham MA
Kimberly Muller - Brookfield CT

Assignee:

CeramOpter Industries, Inc. - East Longmeadow MA

International Classification:

A61D 500

US Classification:

433 1

Abstract:

A laser system and method are described that will improve dental treatments in small animals, particularly in situations where periodontal disease has progressed to the advanced stages of periodontitis and when dental pulp is exposed by fracture or disease. A laser system is employed to achieve enhanced precision by selectively ablating affected tissue without damaging the collateral tissue. The laser system is also capable of sealing the tubules and eradicating bacteria within the periodontium to significantly reduce the risk of infection. Additional pre-treatment methods may be employed to further enhance the laser therapy.

US Patent:

59417013, Aug 24, 1999

Filed:

Jul 14, 1998

Appl. No.:

9/114990

Inventors:

Kelly Moran - Wilbraham MA
Jane Morello - Wilbraham MA
Bill Siminovsky - Ithaca NY
Carol Morello - Wilbraham MA
Kimberly A. Muller - Brookfield CT

International Classification:

A61D 500

US Classification:

433 1

Abstract:

A laser system and method are described that will effectively interrupt the progression of periodontal disease in felines, particularly in situations where the disease has progressed to advanced stages of periodontitis and feline lymphocytic-plasmacytic gingivitis stomatitis. A laser system is employed to achieve precision in surgical procedures where the working field is limited due to the anatomical structure of a feline's mouth. The laser system is also capable of effectively sealing tubules and of eradicating bacteria in the periodontium to significantly reduce the risk of infection. Additionally, the laser therapy can be preceded by pretreatment methods to effectively interrupt the progression of periodontal diseases.